In our study that employed the Irf4–/–TCF1GFP Pmel-1 ACT model, we observed that IRF4 deletion significantly reduced the frequency of transferred Pmel-1 cells in tumor-bearing mice. This evidence concerns the gene IRF4 and neoplasm.